Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 4Neoplasm Metastasis 2Colorectal Neoplasms 2Weight Loss 1Sleep Initiation and Maintenance Disorders 1Protein Deficiency 1Prostatic Neoplasms 1Prolactinoma 1Neoplastic Cells, Circulating 1Neoplasms 1Multiple Myeloma 1Melanoma 1Malnutrition 1Kidney Neoplasms 1Iron Deficiencies 1Hemostasis 1Delirium 1Carcinoma, Renal Cell 1Anemia 1

Interventions

Epoetin Alfa 8ferric carboxymaltose 6epoetin beta 6Darbepoetin alfa 4ferrous sulfate 2ferrous fumarate 2Radiotherapy 2iron isomaltoside 1000 1ferrous succinate 1ferric gluconate 1Vitamin B 12 1Thiotepa 1Standard of Care 1Hematinics 1Folic Acid 1Filgrastim 1Erythropoietin 1Cyclophosphamide 1Cisplatin 1Cholecalciferol 1Brachytherapy 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Anemia × Standard of Care × Clear all
NCT00224068 2012-03-02

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Watson Pharmaceuticals

Phase 4 Completed
180 enrolled
Classical hematology

Iron Deficiencies, Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡